<DOC>
	<DOCNO>NCT02662036</DOCNO>
	<brief_summary>This study evaluate efficacy analgesia provide liposomal bupivacaine ( Exparel ) compare bupivacaine HCL transverse abdominis plane ( TAP ) block term discharge milestone , opioid use , cost , patient-reported satisfaction 12 , 24 , 72 hour . The investigator propose Exparel low opioid use , length stay , overall cost abdominally-based autologous breast reconstruction , lead great patient satisfaction .</brief_summary>
	<brief_title>Analgesic Efficacy Liposomal Bupivacaine vs. Bupivacaine HCL Tap Block After Abdominally Based Autologous Breast Reconstruction</brief_title>
	<detailed_description />
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Scheduled abdominalbased autologous breast reconstruction ( DIEP , MSTRAM , TRAM ) . At least 18 year age . Female . Able understand willing sign write informed consent document . Cognitive impairment . History abdominal surgery preclude free flap donor site . Allergy intolerance bupivacaine `` amide '' anesthetic . Significant preoperative chronic pain ( require daily narcotic ) neuropathic pain ( require daily use pregabalin gabapentin ) within previous 3 month . Pregnant breastfeeding .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>